Retatrutide (10mg)
-
-
| Quantity | Discount | Price |
|---|---|---|
| 9 + | 7% | $3,400.62 |
Research Benefits:
Multi-Receptor Activation: Retatrutide functions as a triple agonist of GLP-1, GIP, and glucagon receptors, offering researchers a unique model for investigating combined incretin and metabolic pathway signaling.
Obesity & Weight Regulation: Commonly utilized in studies analyzing appetite suppression, energy expenditure, and body weight modulation via central and peripheral mechanisms.
Glucose Homeostasis: Used in metabolic models exploring insulin sensitivity, blood glucose regulation, and beta-cell preservation in type 2 diabetes research.
Endocrine and Pancreatic Studies: Supports research on incretin hormones, pancreatic function, and dual/triple receptor agonism for advanced endocrine modeling.
Pharmaceutical-Grade Quality: Produced with >99% purity in lyophilized form, ideal for in vitro applications and controlled preclinical environments.
Money Back
Gaurantee
Satisfaction
Guarantee
Same Day
Shipping
99%
Purity
Premium
Quality
Third Party
Tested
Retatrutide (10mg)
Multi-Receptor Peptide for Metabolic and Weight Management Research
Retatrutide (10mg) is a novel research peptide designed for the investigation of advanced metabolic pathways and weight regulation mechanisms. As a triple-agonist targeting GLP-1, GIP, and glucagon receptors, Retatrutide is a promising compound in preclinical research models focusing on energy balance, fat metabolism, and glucose homeostasis.
Product Overview
Each vial contains 10mg of high-purity lyophilized Retatrutide, ideal for controlled studies examining its multi-pathway action. Researchers utilize this peptide to explore its potential effects on insulin sensitivity, lipid oxidation, and appetite regulation, contributing to the growing field of metabolic disorder treatment models.
Key Research Attributes:
- Triple-Receptor Agonism: Simultaneously activates GLP-1, GIP, and glucagon receptors, enabling research into synergistic effects on metabolism and weight modulation.
- Metabolic Disorder Applications: Frequently used in studies related to obesity, type 2 diabetes, and insulin resistance mechanisms.
- Energy Balance Modulation: Investigated for its ability to reduce food intake, enhance thermogenesis, and improve glycemic control in animal models.
- Laboratory-Grade Purity: Formulated for stability, accuracy, and consistency across experimental trials in metabolic and endocrinology labs.
Applications in Scientific Research
- GLP-1/GIP/glucagon receptor signaling studies
- Obesity and fat oxidation research models
- Preclinical evaluation of multi-targeted weight loss peptides
- Endocrine regulation and appetite hormone analysis
- Type 2 diabetes and insulin response studies
Format and Storage
Form: Lyophilized powder
Purity: >99%
Storage: Store at -20°C for optimal long-term stability
Reconstitution: Use bacteriostatic water for preparation in laboratory settings
Disclaimer: Retatrutide (10mg) is supplied strictly for research and in vitro laboratory use. It is not intended for human or veterinary application. All usage must comply with institutional and regulatory guidelines.
Chemical Makeup
Molecular Formula
- Retatrutide: C310H481N87O94
Molecular Weight
- Retatrutide: 6959.5 g/mol
Sequence
- Retatrutide: Full amino acid sequence proprietary to ongoing research; known for GLP-1/GIP/glucagon triple-agonist activity.
Other Known Titles
- Retatrutide: LY3437943, Triple Agonist Peptide
Retatrutide (10mg) is intended exclusively for research and scientific laboratory use. Please review our Terms and Conditions before ordering.
| Research | Retatrutide: Effects, Benefits, and Side EffectsRetatrutide is an investigational peptide that functions as a triple-receptor agonist, targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This multifaceted mechanism aims to enhance metabolic regulation, offering potential benefits in weight management and glycemic control. Below are ten reputable sources providing comprehensive insights into Retatrutide’s effects, benefits, and potential side effects:
|
|---|
Retatrutide: Effects, Benefits, and Side Effects
Retatrutide is an investigational peptide that functions as a triple-receptor agonist, targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This multifaceted mechanism aims to enhance metabolic regulation, offering potential benefits in weight management and glycemic control. Below are ten reputable sources providing comprehensive insights into Retatrutide’s effects, benefits, and potential side effects:
- “Retatrutide: Uses, Side Effects, Availability and More”
This article explores Retatrutide’s mechanism of action, emphasizing its role in reducing appetite and slowing digestion through GLP-1 receptor activation. It also discusses potential side effects, including gastrointestinal disturbances.
Read more - “Retatrutide Overview, Dosage, and Risks”
This source provides an overview of Retatrutide, detailing common side effects such as nausea, vomiting, diarrhea, and abdominal pain, particularly during initial treatment phases.
Read more - “Retatrutide: Side Effects, Complications, and Risk Profile”
This article examines the side effect profile of Retatrutide, focusing on gastrointestinal issues and the importance of proper dosing to minimize adverse effects.
Read more - “What to Know About Retatrutide Weight-Loss Drug”
This piece discusses Retatrutide’s potential in weight loss, comparing its efficacy to other GLP-1 agonists, and notes common side effects like nausea and constipation.
Read more - “What are the Side Effects of Retatrutide?”
This article outlines the gastrointestinal side effects associated with Retatrutide, such as nausea, vomiting, diarrhea, and constipation, and suggests that gradual dose escalation may help manage these effects.
Read more - “Everything You Need to Know About Retatrutide”
This comprehensive overview explains Retatrutide’s triple-receptor targeting mechanism and its implications for hunger regulation, insulin production, and fat metabolism.
Read more - “Retatrutide UK Explained: Benefits, Dosage, and Side Effects”
This source discusses Retatrutide’s classification as a peptide-based medication, its potential benefits in managing type 2 diabetes and obesity, and associated side effects.
Read more - “Understanding Retatrutide: A Novel Drug for Weight Loss”
This article provides insights into Retatrutide’s dosing schedules, administration methods, and strategies to minimize side effects during clinical trials.
Read more - “Retatrutide Dosage Calculator and Chart”
This resource offers detailed information on Retatrutide’s dosing protocols and discusses its side effect profile, emphasizing the importance of adherence to recommended dosages.
Read more - “New Drug Retatrutide Outshines Ozempic and Helps People Lose Quarter of Weight”
This news article highlights clinical trial results indicating significant weight loss with Retatrutide and discusses its side effects, including nausea and constipation.
Read more
Log In